Balloon atrial septostomy in hypoplastic left heart syndrome with restrictive atrial septum.


Journal

Pediatrics international : official journal of the Japan Pediatric Society
ISSN: 1442-200X
Titre abrégé: Pediatr Int
Pays: Australia
ID NLM: 100886002

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 01 03 2018
revised: 12 09 2018
accepted: 12 10 2018
pubmed: 20 10 2018
medline: 11 5 2019
entrez: 20 10 2018
Statut: ppublish

Résumé

Rashkind balloon atrial septostomy (BAS) can be challenging in infants with hypoplastic left heart syndrome (HLHS) and small atrial septal defect (ASD). We retrospectively reviewed all infants with HLHS who underwent surgery and BAS between January 2006 and December 2015. The infants were divided into three groups: no BAS; catheter BAS; and open AS. Infants who underwent catheter BAS were divided into two groups based on atrial septal anatomy: standard and complex. Of the 70 patients, 57 (81%) underwent Glenn surgery. Subsequently, a significant difference in survival was observed: 86% (44/51), 91% (10/11), and 25% (2/8) in the no BAS, catheter BAS, and open AS groups, respectively (P = 0.0002). No significant difference was seen between the no BAS and the catheter BAS groups (P = 1.0). In the 56 patients who underwent catheterization after surgery, no intergroup differences in mean pulmonary artery pressure, pulmonary vascular resistance, or pulmonary artery index were found. We classified catheter BAS into standard (n = 5) and complex (n = 5) based on ASD location, and septum thickness. All patients in the standard group underwent complete Rashkind BAS, but in the complex group, only one patient underwent complete Rashkind BAS, with the remaining requiring initial static BAS (P = 0.048). Following septostomy, ASD size, ASD flow, and percutaneous oxygen saturation (SpO Catheter BAS is effective in infants with HLHS and a restrictive atrial septum. Infants with standard or complex atrial septum can achieve equivalent outcomes despite more patients often requiring static BAS.

Sections du résumé

BACKGROUND BACKGROUND
Rashkind balloon atrial septostomy (BAS) can be challenging in infants with hypoplastic left heart syndrome (HLHS) and small atrial septal defect (ASD).
METHODS METHODS
We retrospectively reviewed all infants with HLHS who underwent surgery and BAS between January 2006 and December 2015. The infants were divided into three groups: no BAS; catheter BAS; and open AS. Infants who underwent catheter BAS were divided into two groups based on atrial septal anatomy: standard and complex.
RESULTS RESULTS
Of the 70 patients, 57 (81%) underwent Glenn surgery. Subsequently, a significant difference in survival was observed: 86% (44/51), 91% (10/11), and 25% (2/8) in the no BAS, catheter BAS, and open AS groups, respectively (P = 0.0002). No significant difference was seen between the no BAS and the catheter BAS groups (P = 1.0). In the 56 patients who underwent catheterization after surgery, no intergroup differences in mean pulmonary artery pressure, pulmonary vascular resistance, or pulmonary artery index were found. We classified catheter BAS into standard (n = 5) and complex (n = 5) based on ASD location, and septum thickness. All patients in the standard group underwent complete Rashkind BAS, but in the complex group, only one patient underwent complete Rashkind BAS, with the remaining requiring initial static BAS (P = 0.048). Following septostomy, ASD size, ASD flow, and percutaneous oxygen saturation (SpO
CONCLUSIONS CONCLUSIONS
Catheter BAS is effective in infants with HLHS and a restrictive atrial septum. Infants with standard or complex atrial septum can achieve equivalent outcomes despite more patients often requiring static BAS.

Identifiants

pubmed: 30339315
doi: 10.1111/ped.13716
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

339-344

Informations de copyright

© 2018 Japan Pediatric Society.

Auteurs

Yosuke Fukushima (Y)

Department of Pediatric Cardiology, Okayama University Hospital, Kita, Okayama, Japan.

Kenji Baba (K)

Department of Pediatric Cardiology, Okayama University Hospital, Kita, Okayama, Japan.

Maiko Kondo (M)

Department of Pediatric Cardiology, Okayama University Hospital, Kita, Okayama, Japan.

Yoshihiko Kurita (Y)

Department of Pediatric Cardiology, Okayama University Hospital, Kita, Okayama, Japan.

Takahiro Eitoku (T)

Department of Pediatric Cardiology, Okayama University Hospital, Kita, Okayama, Japan.

Yusuke Shigemitsu (Y)

Department of Pediatric Cardiology, Okayama University Hospital, Kita, Okayama, Japan.

Kenta Hirai (K)

Department of Pediatric Cardiology, Okayama University Hospital, Kita, Okayama, Japan.

Hirokazu Tsukahara (H)

Department of Pediatrics, Okayama University Hospital, Kita, Okayama, Japan.

Tatsuo Iwasaki (T)

Department of Pediatric Anesthesiology, Okayama University Hospital, Kita, Okayama, Japan.

Shingo Kasahara (S)

Department of Cardiovascular Surgery, Okayama University Hospital, Kita, Okayama, Japan.

Yasuhiro Kotani (Y)

Department of Cardiovascular Surgery, Okayama University Hospital, Kita, Okayama, Japan.

Shinichi Otsuki (S)

Department of Pediatric Cardiology, Okayama University Hospital, Kita, Okayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH